3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
Cyclophosphamide
91
Rituximab
80
Specimen Handling
75
Magnetic Resonance Spectroscopy
64
Biopsy
59
Doxorubicin
48
Prednisone
47
Vincristine
46
venetoclax
38
obinutuzumab
35
fludarabine
34
ibrutinib
29
Lenalidomide
29
Dexamethasone
27
Cytarabine
27
Methotrexate
25
Etoposide
24
prednylidene
23
CT-P10
23
zanubrutinib
22
deltacortene
22
blinatumomab
22
acalabrutinib
22
fludarabine phosphate
21
Nivolumab
21
merphos
18
pembrolizumab
16
Bendamustine Hydrochloride
16
Mercaptopurine
15
Calcium Dobesilate
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
parsaclisib
×
Lymphoid
×
30 days
×
Clear all
NCT04661007
2026-05-18
J-MIND
Incyte Corporation
Phase 1/2
Active not recruiting
72 enrolled